Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 8INDUSTRY 7NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 1CNS 1

Conditions

Rectal Neoplasms 23Colonic Neoplasms 16Colorectal Neoplasms 14Breast Neoplasms 11Stomach Neoplasms 5Pancreatic Neoplasms 5Bile Duct Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Liver Neoplasms 3Gallbladder Neoplasms 3Breast Neoplasms, Male 3Neoplasm Metastasis 2Inflammatory Breast Neoplasms 2Head and Neck Neoplasms 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Somatostatinoma 1Sezary Syndrome 1Salivary Gland Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pancreatic Intraductal Neoplasms 1Ovarian Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Cisplatin 23Radiotherapy 22Cetuximab 17Magnetic Resonance Spectroscopy 12Radiotherapy, Intensity-Modulated 10Fluorouracil 10Specimen Handling 9Platinum 91,2-diaminocyclohexaneplatinum II citrate 9pembrolizumab 8Erlotinib Hydrochloride 8Docetaxel 8Carboplatin 8Paclitaxel 7Biopsy 7Bevacizumab 7Radiation 5(225)Ac-DOTA-c(RGDyK) 5Hydroxyurea 4Gefitinib 4Radiosurgery 3Immunoglobulin G 3Disulfides 3Chemotherapy, Adjuvant 3Capecitabine 3ixabepilone 2dehydroftorafur 2atezolizumab 2aldesleukin 2Vorinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Squamous Cell Carcinoma of Head and Neck × Capecitabine × Clear all
NCT01267240 2017-04-14

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
25 enrolled 9 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00021047 2012-03-08

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00114153 2009-11-26

Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Completed
48 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡